ALB vs DXR · rev $1.74B vs P/E 6.5, rev $1.4M
Albemarle Corp (ALB) versus Daxor Corporation (DXR) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
ALB currently screens at market cap $8.00B. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
Not investment advice. Open the ALB and DXR stock pages for the full models.
Not investment advice.